Brian Corvese - 01 Dec 2022 Form 4 Insider Report for MiNK Therapeutics, Inc. (INKT)

Role
Director
Signature
By: /s/ Christine Klaskin, Attorney-in-Fact
Issuer symbol
INKT
Transactions as of
01 Dec 2022
Transactions value $
$17,876
Form type
4
Filing time
05 Dec 2022, 16:20:28 UTC
Previous filing
19 Sep 2022
Next filing
03 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INKT Common Stock Award $17.9K +6.85K +2.35% $2.61 299K 01 Dec 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date.
F2 Amount owned includes 278,300 shares that were inadvertently excluded from a Form 4 filed on September 19, 2022.